Medication info
Aroset Tablet 10 mg (Donepezil Hydrochloride Monohydrate)

Aroset Tablet 10 mg (Donepezil Hydrochloride Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Donepezil Hydrochloride Hydrate›10mg / 1 tablet
Manufacturer / importer
Samnam Pharmaceutical Co., Ltd.
Appearance
Yellow, round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201804333 · Approved 2018.10.31 · Insurance code 653702270

Summary

Main use
Treatment of symptoms of Alzheimer-type dementia
Who takes it
Adults · Children
Adult dose
○ Adults: Administer donepezil hydrochloride 5 mg once daily at bedtime. If sleep disturbances such as abnormal dreams, nightmares, or insomnia occur, taking this medicine in the morning may be considered. Since donepezil concentrations reach steady state 15 days after administration and the frequency of adverse reactions may be affected by the rate of dose increase, administer the 5 mg dose for 4~6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg daily, administer with caution for gastrointestinal adverse reactions. When treatment with this medicine is discontinued, its effect gradually decreases, and no rebound effect occurs with abrupt discontinuation. ○ Women aged 85 years or older with low body weight: Careful monitoring is necessary because adverse reactions occur more frequently. Elderly women with low body weight should not exceed 5 mg daily.
Child dose
○ Children: There is no experience with use in children.

Ingredients

Manufacturer
Samnam Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of symptoms of Alzheimer-type dementia

  • Symptoms of Alzheimer's type dementia
View approved original text

This medication is used for the treatment of symptoms of Alzheimer's type dementia. It helps improve cognitive function impairment due to dementia, assisting patients with memory and daily living abilities. It helps delay the progression of symptoms and maintain independence in daily life.

How to take

Adult dose

○ Adults: Administer donepezil hydrochloride 5 mg once daily at bedtime. If sleep disturbances such as abnormal dreams, nightmares, or insomnia occur, taking this medicine in the morning may be considered. Since donepezil concentrations reach steady state 15 days after administration and the frequency of adverse reactions may be affected by the rate of dose increase, administer the 5 mg dose for 4~6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg daily, administer with caution for gastrointestinal adverse reactions. When treatment with this medicine is discontinued, its effect gradually decreases, and no rebound effect occurs with abrupt discontinuation. ○ Women aged 85 years or older with low body weight: Careful monitoring is necessary because adverse reactions occur more frequently. Elderly women with low body weight should not exceed 5 mg daily.

Child dose

○ Children: There is no experience with use in children.

Precautions

This medication contains Donepezil Hydrochloride Monohydrate as the active ingredient and is mainly used to treat symptoms of Alzheimer's type dementia. This medication should not be used in patients allergic to Donepezil Hydrochloride or piperidine derivatives, or any component of the drug. Additionally, pregnant women or women who may become pregnant, as well as lactating women, should not take this medication. This medication contains lactose, so it should not be administered to patients with genetic metabolic disorders such as lactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. Patients with heart diseases, particularly those with bradycardia or atrioventricular conduction disturbances, should be cautious because this medication may cause bradycardia or arrhythmias through vagal stimulation. Patients taking non-steroidal anti-inflammatory drugs or those with a history of peptic ulcers should use this medication cautiously as it may exacerbate symptoms due to increased gastric acid secretion and gastrointestinal motility. Patients with a history of asthma or obstructive pulmonary disease may experience worsened symptoms due to bronchoconstriction and increased mucus secretion, requiring caution. Moreover, patients with Parkinson's disease or similar extrapyramidal disorders may have exacerbated symptoms, as this medication stimulates cholinergic neurons. This medication contains Yellow No. 5 dye, so patients with hypersensitivity or allergic history to this component should be careful. During treatment, cardiovascular adverse reactions such as syncope, bradycardia, heart block, myocardial infarction, heart failure, and severe adverse reactions like peptic ulcers, gastrointestinal bleeding, hepatitis, cerebral seizures, extrapyramidal disorders, neuroleptic malignant syndrome, rhabdomyolysis, respiratory distress, acute pancreatitis, acute renal failure, and sudden death may occur. If symptoms arise, consult a healthcare professional immediately. Common side effects that may occur include nausea, vomiting, diarrhea, loss of appetite, dizziness, insomnia, headache, and fatigue. This medication is not approved for other types of dementia or memory disorders aside from Alzheimer's type dementia and should only be used under the diagnosis and supervision of an experienced physician. Patients with cardiovascular diseases or a history of QT interval prolongation may require ECG monitoring while taking this medication. As a cholinesterase inhibitor, this medication may enhance the effect of succinylcholine-type muscle relaxants during anesthesia, so it is crucial to inform healthcare providers before anesthesia. This medication is primarily metabolized in the liver and may show increased or decreased efficacy when taken with certain drugs, so inform healthcare providers of any concurrent medications. Pregnant or lactating women are advised against taking this medication, and if it is necessary, discontinuing breastfeeding is recommended. Safety in pediatric patients has not been established; thus, it is not used in children. In case of overdose, symptoms such as nausea, vomiting, sweating, bradycardia, hypotension, respiratory depression, and seizures may occur; in such cases, seek emergency treatment immediately, and atropine may be used as an antidote. This medication should be kept out of reach of children, and transferring it to another container should be avoided due to the risk of accidental ingestion and degradation of quality.

Side effects

  • Fainting
  • bradycardia
  • heart block
  • prolonged QT interval
  • myocardial infarction
  • heart failure
  • peptic ulcer
  • perforated duodenum
  • gastrointestinal bleeding
  • hepatitis
Show 230 more
  • liver function impairment
  • jaundice
  • cerebral seizures
  • epilepsy
  • convulsions
  • cerebral hemorrhage
  • cerebrovascular disorders
  • motor dysfunction
  • ataxia
  • movement disorders
  • dystonia
  • tremor
  • involuntary movement
  • gait disturbances
  • abnormal posture
  • speech disorders
  • akinetic mutism
  • extreme muscle rigidity
  • dysphagia
  • tachycardia
  • blood pressure fluctuations
  • sweating
  • myoglobinuria
  • renal dysfunction
  • myalgia
  • weakness
  • dyspnea
  • acute pancreatitis
  • acute renal failure
  • sudden death
  • cold
  • anorexia
  • hallucinations
  • agitation
  • aggressive behavior
  • anxiety disorders
  • insomnia
  • drowsiness
  • increased libido
  • talkativeness
  • mania
  • nightmares
  • nervous hypersensitivity
  • incoherence
  • delusions
  • depression
  • confusion
  • apathy
  • hyperactivity
  • increased sexual desire
  • hypersexuality
  • dizziness
  • tremor
  • stupor
  • chest rigidity
  • palpitations
  • sinoatrial block
  • atrioventricular block
  • hypertension
  • hypotension
  • atrial fibrillation
  • torsades de pointes
  • diarrhea
  • nausea
  • vomiting
  • abdominal disorders
  • constipation
  • salivation
  • fecal incontinence
  • rash
  • itching
  • muscle cramps
  • myalgia
  • urinary incontinence
  • frequent urination
  • urinary retention
  • headache
  • fatigue
  • pain
  • toothache
  • facial flushing
  • malaise
  • asthenia
  • edema
  • fever
  • decreased body temperature
  • decreased hematocrit
  • leukopenia
  • anemia
  • thrombocytopenia
  • cardiac arrest
  • urinary tract infection
  • decreased appetite
  • hematological abnormalities
  • increased CPK
  • dehydration
  • hyperlipidemia
  • insomnia
  • hostility
  • irritability
  • drowsiness
  • depression
  • confusion
  • emotional instability
  • personality disorder
  • eczema
  • urinary incontinence
  • abdominal pain
  • weakness
  • fungal infections
  • influenza-like illness
  • allergy
  • soft tissue infection
  • malaise
  • sepsis
  • facial edema
  • hernia
  • hypotension
  • abnormal ECG
  • heart failure
  • myocardial infarction
  • angina pectoris
  • atrial fibrillation
  • congestive heart failure
  • peripheral vascular disease
  • supraventricular extrasystole
  • ventricular extrasystole
  • cardiac hypertrophy
  • constipation
  • gastroenteritis
  • fecal incontinence
  • dyspepsia
  • increased γ-GT
  • gastritis
  • dysphagia
  • periodontitis
  • gastric ulcer
  • periodontal abscess
  • abdominal distension
  • liver dysfunction
  • belching
  • esophagitis
  • rectal bleeding
  • diabetes
  • anemia
  • leukocytosis
  • weight loss
  • peripheral edema
  • edema
  • increased LDH
  • increased alkaline phosphatase
  • hypercholesterolemia
  • hypokalemia
  • hypoglycemia
  • weight gain
  • hyperbilirubinemia
  • increased BUN
  • B12 deficiency anemia
  • cachexia
  • increased creatinine
  • gout
  • hyponatremia
  • hypoalbuminemia
  • iron deficiency anemia
  • increased AST
  • increased ALT
  • arthritis
  • arthrosis
  • bone fracture
  • arthralgia
  • leg cramps
  • osteoporosis
  • anxiety
  • agitation
  • convulsions
  • transient mental disorders
  • gait abnormalities
  • apathy
  • delusions
  • dream disorders
  • cerebrovascular abnormalities
  • increased salivation
  • ataxia
  • ecstasy
  • vasodilation
  • cerebral hemorrhage
  • cerebral infarction
  • cerebral ischemia
  • dementia
  • extrapyramidal symptoms
  • grand mal convulsions
  • hemiplegia
  • heightened tension
  • decreased mobility
  • pharyngitis
  • pneumonia
  • increased cough
  • bronchitis
  • rhinitis
  • asthma
  • skin ulcer
  • psoriasis
  • skin discoloration
  • shingles
  • dry skin
  • hives
  • vesicular rash
  • conjunctivitis
  • glaucoma
  • visual disturbances
  • ear pain
  • tear abnormalities
  • urinary tract infection
  • cystitis
  • hematuria
  • vaginitis
  • voiding disorders
  • proteinuria
  • abdominal pain
  • anxiety
  • cholecystitis
  • confusion
  • convulsions
  • hallucinations
  • heart block
  • hemolytic anemia
  • hyponatremia
  • neuroleptic malignant syndrome
  • pancreatitis
  • rash

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container that is air-tight, at room temperature between 1 and 30 degrees Celsius. Proper storage helps maintain efficacy and prevent deterioration.

Appearance and packaging

Appearance

Yellow, round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.